Evaxion Biotech A/S ADR (EVAX)

$1.66 +0.02 (1.22%)
Market Cap 2.30M
Revenue (ttm) 3.34M
Net Income (ttm) -10.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -316.47%
Debt to Equity Ratio -4.95
Volume 57,600
Avg Vol 68,002
Day's Range N/A - N/A
Shares Out 1.40M
Stochastic %K 76%
Beta -0.24
Analysts Strong Sell
Price Target $13.25

Company Profile

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers, including non-small...

Industry: Biotechnology
Sector: Healthcare
Phone: 45 31 31 97 53
Website: evaxion.ai
Address:
Dr. Neergaards Vej, 5th Floor, Horsholm, Denmark
Pitts123
Pitts123 Sep. 8 at 10:33 PM
$EVAX What is $MRK waiting on? They're going to be sick when they partner with someone else you should BO now while it's low.
0 · Reply
SmartMoneyWins
SmartMoneyWins Sep. 6 at 7:08 PM
SKYQ is the ticker that should be on everyone's top list! This will be the next penny to go big! "Sky Quarry Announces Strategic Digital Asset Initiative." -Strategic expansion into digital assets to diversify company's treasury holdings. -Early mover advantage in energy sector's digital assets adoption. -Potential to create a new revenue streams through blockchain integration Make sure you get SKYQ and lets bank on it. $CTMX $EVAX $LGHL $JEM Good runs.
1 · Reply
S2K_TradeZ
S2K_TradeZ Sep. 6 at 6:09 AM
$EVAX flirting with that $3.00 breakout. This setup is getting tight. MACD and RSI turning bullish on multiple timeframes. $3.00 is the psychological and chart resistance — clean break could open $3.40–$3.60. Topwatch 🚨
0 · Reply
revueltoL
revueltoL Sep. 4 at 4:28 PM
$EVAX started a position…last time my position did well, and I think it will again this time..
1 · Reply
Manwiththeplan
Manwiththeplan Sep. 3 at 8:55 PM
$EVAX unexpected drop.
1 · Reply
Manwiththeplan
Manwiththeplan Sep. 3 at 12:44 PM
$EVAX waiting for news.... I really hope that will be news before october
0 · Reply
Dingo2
Dingo2 Aug. 28 at 4:46 PM
$EVAX volume is a no-show today. Strange...
1 · Reply
Manwiththeplan
Manwiththeplan Aug. 27 at 2:13 PM
$EVAX https://finance.yahoo.com/news/evaxion-present-several-conferences-during-120000699.html I hate this kind of press releases. What is the point? Seems to be hard to find deals
0 · Reply
Manwiththeplan
Manwiththeplan Aug. 26 at 3:08 PM
$EVAX people are waiting.
0 · Reply
Rampageusa
Rampageusa Aug. 24 at 2:57 PM
$EVAX consolidation 5/7+ soon in few weeks,
0 · Reply
Latest News on EVAX
Evaxion A/S (EVAX) Q2 2025 Earnings Call Transcript

Aug 19, 2025, 3:29 PM EDT - 20 days ago

Evaxion A/S (EVAX) Q2 2025 Earnings Call Transcript

Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025

Aug 11, 2025, 8:00 AM EDT - 4 weeks ago

Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025

Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025

Jul 25, 2025, 9:00 AM EDT - 6 weeks ago

Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025

Evaxion finalizes agreement with EIB to convert debt into equity

Jul 11, 2025, 8:00 AM EDT - 2 months ago

Evaxion finalizes agreement with EIB to convert debt into equity

Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio

Jul 1, 2025, 8:30 AM EDT - 2 months ago

Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio

Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus

Jun 25, 2025, 8:00 AM EDT - 2 months ago

Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus

Evaxion receives grant funding to design new polio vaccine

Jun 3, 2025, 9:15 AM EDT - 3 months ago

Evaxion receives grant funding to design new polio vaccine

Evaxion Biotech A/S (EVAX) Q1 2025 Earnings Conference Call Transcript

May 27, 2025, 10:43 AM EDT - 3 months ago

Evaxion Biotech A/S (EVAX) Q1 2025 Earnings Conference Call Transcript

Evaxion announces business update and first quarter 2025 financial results

May 27, 2025, 7:30 AM EDT - 3 months ago

Evaxion announces business update and first quarter 2025 financial results

Evaxion: Progress Unrecognized By Market And A Catalyst-Full 2025

May 26, 2025, 8:47 AM EDT - 3 months ago

Evaxion: Progress Unrecognized By Market And A Catalyst-Full 2025

Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025

May 23, 2025, 8:00 AM EDT - 3 months ago

Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025

Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01

May 22, 2025, 8:00 AM EDT - 3 months ago

Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01

80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting

Apr 28, 2025, 8:00 AM EDT - 4 months ago

80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting

Evaxion to present at World Vaccine Congress

Apr 10, 2025, 8:00 AM EDT - 5 months ago

Evaxion to present at World Vaccine Congress

Evaxion Biotech A/S (EVAX) Q4 2024 Earnings Call Transcript

Apr 1, 2025, 11:21 AM EDT - 5 months ago

Evaxion Biotech A/S (EVAX) Q4 2024 Earnings Call Transcript

Evaxion to announce business update and full year 2024 financial results on April 1, 2025

Mar 27, 2025, 8:00 AM EDT - 5 months ago

Evaxion to announce business update and full year 2024 financial results on April 1, 2025

Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting

Mar 25, 2025, 4:30 PM EDT - 5 months ago

Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting

Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package

Feb 25, 2025, 8:00 AM EST - 6 months ago

Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package

Evaxion announces closing of $10.8 million public offering

Jan 31, 2025, 4:05 PM EST - 7 months ago

Evaxion announces closing of $10.8 million public offering

Evaxion announces pricing of $10.8 million public offering

Jan 30, 2025, 8:00 AM EST - 7 months ago

Evaxion announces pricing of $10.8 million public offering

Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement

Jan 28, 2025, 8:15 AM EST - 7 months ago

Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement

Evaxion announces completion of ADS ratio change

Jan 14, 2025, 4:05 PM EST - 8 months ago

Evaxion announces completion of ADS ratio change

Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change

Jan 10, 2025, 8:00 AM EST - 8 months ago

Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change

Evaxion announces plan to implement ADS ratio change

Dec 30, 2024, 8:00 AM EST - 9 months ago

Evaxion announces plan to implement ADS ratio change

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1

Nov 12, 2024, 8:00 AM EST - 10 months ago

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1

Evaxion announces business update and third quarter 2024 financial results

Oct 31, 2024, 8:00 AM EDT - 11 months ago

Evaxion announces business update and third quarter 2024 financial results

Evaxion to announce business update and third quarter 2024 financial results on October 31

Oct 28, 2024, 8:00 AM EDT - 11 months ago

Evaxion to announce business update and third quarter 2024 financial results on October 31

Strong validation of Evaxion's AI-Immunology™ platform in multiple clinical trials

Oct 9, 2024, 8:00 AM EDT - 11 months ago

Strong validation of Evaxion's AI-Immunology™ platform in multiple clinical trials

Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform

Oct 3, 2024, 8:00 AM EDT - 1 year ago

Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform

Evaxion Biotech Partners With Merck To Expand Vaccine Development

Sep 26, 2024, 10:53 AM EDT - 1 year ago

Evaxion Biotech Partners With Merck To Expand Vaccine Development

MRK

Evaxion significantly expands vaccine development collaboration with MSD

Sep 26, 2024, 7:30 AM EDT - 1 year ago

Evaxion significantly expands vaccine development collaboration with MSD

Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction

Sep 19, 2024, 8:00 AM EDT - 1 year ago

Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction

Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2

Sep 9, 2024, 7:00 AM EDT - 1 year ago

Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2

Evaxion Biotech A/S (EVAX) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 11:43 AM EDT - 1 year ago

Evaxion Biotech A/S (EVAX) Q2 2024 Earnings Call Transcript

Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14

Aug 12, 2024, 7:27 AM EDT - 1 year ago

Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14

Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September

Aug 8, 2024, 8:00 AM EDT - 1 year ago

Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September

Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference

Jul 16, 2024, 7:30 AM EDT - 1 year ago

Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference

Evaxion Reinforces Milestone Timeline and Provides Shareholder Update

Jul 3, 2024, 8:05 AM EDT - 1 year ago

Evaxion Reinforces Milestone Timeline and Provides Shareholder Update

Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method

Jun 26, 2024, 7:30 AM EDT - 1 year ago

Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method

Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal

Jun 17, 2024, 8:44 AM EDT - 1 year ago

Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal

Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024

Jun 3, 2024, 8:00 AM EDT - 1 year ago

Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024

Evaxion Announces Business Update and First Quarter 2024 Financial Results

May 28, 2024, 8:21 AM EDT - 1 year ago

Evaxion Announces Business Update and First Quarter 2024 Financial Results

Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024

May 23, 2024, 5:00 PM EDT - 1 year ago

Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024

Evaxion Receives Nasdaq Notification

May 10, 2024, 5:00 PM EDT - 1 year ago

Evaxion Receives Nasdaq Notification

Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01

Apr 17, 2024, 8:00 AM EDT - 1 year ago

Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01

Evaxion Biotech A/S (EVAX) Q4 2023 Earnings Call Transcript

Apr 2, 2024, 2:10 PM EDT - 1 year ago

Evaxion Biotech A/S (EVAX) Q4 2023 Earnings Call Transcript

Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection

Apr 2, 2024, 7:00 AM EDT - 1 year ago

Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection

Evaxion Announces Business Update and Full Year 2023 Financial Results

Mar 27, 2024, 7:30 AM EDT - 1 year ago

Evaxion Announces Business Update and Full Year 2023 Financial Results

Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform

Mar 19, 2024, 7:30 AM EDT - 1 year ago

Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform

Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations

Feb 29, 2024, 7:30 AM EST - 1 year ago

Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations

Pitts123
Pitts123 Sep. 8 at 10:33 PM
$EVAX What is $MRK waiting on? They're going to be sick when they partner with someone else you should BO now while it's low.
0 · Reply
SmartMoneyWins
SmartMoneyWins Sep. 6 at 7:08 PM
SKYQ is the ticker that should be on everyone's top list! This will be the next penny to go big! "Sky Quarry Announces Strategic Digital Asset Initiative." -Strategic expansion into digital assets to diversify company's treasury holdings. -Early mover advantage in energy sector's digital assets adoption. -Potential to create a new revenue streams through blockchain integration Make sure you get SKYQ and lets bank on it. $CTMX $EVAX $LGHL $JEM Good runs.
1 · Reply
S2K_TradeZ
S2K_TradeZ Sep. 6 at 6:09 AM
$EVAX flirting with that $3.00 breakout. This setup is getting tight. MACD and RSI turning bullish on multiple timeframes. $3.00 is the psychological and chart resistance — clean break could open $3.40–$3.60. Topwatch 🚨
0 · Reply
revueltoL
revueltoL Sep. 4 at 4:28 PM
$EVAX started a position…last time my position did well, and I think it will again this time..
1 · Reply
Manwiththeplan
Manwiththeplan Sep. 3 at 8:55 PM
$EVAX unexpected drop.
1 · Reply
Manwiththeplan
Manwiththeplan Sep. 3 at 12:44 PM
$EVAX waiting for news.... I really hope that will be news before october
0 · Reply
Dingo2
Dingo2 Aug. 28 at 4:46 PM
$EVAX volume is a no-show today. Strange...
1 · Reply
Manwiththeplan
Manwiththeplan Aug. 27 at 2:13 PM
$EVAX https://finance.yahoo.com/news/evaxion-present-several-conferences-during-120000699.html I hate this kind of press releases. What is the point? Seems to be hard to find deals
0 · Reply
Manwiththeplan
Manwiththeplan Aug. 26 at 3:08 PM
$EVAX people are waiting.
0 · Reply
Rampageusa
Rampageusa Aug. 24 at 2:57 PM
$EVAX consolidation 5/7+ soon in few weeks,
0 · Reply
Manwiththeplan
Manwiththeplan Aug. 22 at 5:02 PM
$EVAX $4 in august
0 · Reply
Manwiththeplan
Manwiththeplan Aug. 22 at 4:58 PM
$EVAX This will go up towards ESMO 17th of october
0 · Reply
Manwiththeplan
Manwiththeplan Aug. 21 at 8:05 PM
$EVAX I know i am talking to myself but nice finish.
2 · Reply
Manwiththeplan
Manwiththeplan Aug. 21 at 7:40 PM
$EVAX wake me up @ $10
0 · Reply
Manwiththeplan
Manwiththeplan Aug. 19 at 2:14 PM
$EVAX consolidation today would be nice
0 · Reply
S2K_TradeZ
S2K_TradeZ Aug. 18 at 6:20 PM
$EVAX 3.5 break coming tomorrow? 🚨
2 · Reply
Manwiththeplan
Manwiththeplan Aug. 18 at 2:37 PM
$EVAX nice
0 · Reply
Manwiththeplan
Manwiththeplan Aug. 15 at 5:01 PM
$EVAX - Milestonepayment on track for H2 2025 - 11/16 patients still in study. Most are doing 'extremely' well - multiple ongoing discussions about partnerships
0 · Reply
Manwiththeplan
Manwiththeplan Aug. 15 at 4:47 PM
$EVAX https://youtu.be/NAHLGl9jcxY?si=Qpe_OrSSIbABSgsB
0 · Reply
itsmejeremy
itsmejeremy Aug. 15 at 11:53 AM
$CADL $JNJ $MRK $MRNA $EVAX $TSLA $AAPL $MSFT $AMZN ATTENTION ALL SHORTS: come make EASY FREE money shorting this dog shit. Management is sitting on there asses for 2-3 years and ZERO catalysts until 2027 so you have PLENTY of time. Fuck this stock up no one is here to make money anyway👍
0 · Reply
MT25
MT25 Aug. 14 at 6:03 PM
$EVAX good update today ! Things on track👍💪
0 · Reply
Manwiththeplan
Manwiththeplan Aug. 14 at 3:55 PM
$EVAX were there any good questions at the CC. I could not join.
1 · Reply